Professional Documents
Culture Documents
Jubilant Life
Jubilant Life
Expenses 110% 93% 118% 122% 115% 108% 87% 100% 133%
Operating Profit 99% 83% 158% 112% 100% 61% 206% 108% 113%
Net profit 149% 55% 6% 1049% 71% -53% -678% 147% 112%
JUBILANT LIFE SCIENCES LTD SCREENER.IN
Narration Mar-09 Mar-10 Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18 Trailing Best Case Worst Case 1.01
Sales 3,484.96 3,748.90 3,419.70 4,269.86 5,132.30 5,762.38 5,750.63 5,749.13 5,861.43 7,517.84 8,667.86 9,642.34 8,205.50 1.09
Expenses 2,795.41 3,064.43 2,854.46 3,378.54 4,133.56 4,763.41 5,140.96 4,493.21 4,509.81 5,995.34 6,905.37 7,560.45 6,668.73 1.09
Operating Profit 689.55 684.47 565.24 891.32 998.74 998.97 609.67 1,255.92 1,351.62 1,522.50 1,762.49 2,081.89 1,536.77 1.09
Operating Profit % 19.79 18.26 16.53 20.87 19.46 17.34 10.60 21.85 23.06 20.25 20.33 21.59 18.73 1.00
Other Income 95.87 27.16 -24.56 -318.33 -92.87 -173.42 86.21 4.40 18.52 35.92 39.43 - - 0.90
Other Income % 14% 4% -4% -36% -9% -17% 14% 0% 1% 2% 2% 0% 0% 0.82
EBIDT 785.42 711.63 540.68 572.99 905.87 825.55 695.88 1,260.32 1,370.14 1,558.42 1,801.92 2,081.89 1,536.77 1.08
EBIDT % 22.54 18.98 15.81 13.42 17.65 14.33 12.10 21.92 23.38 20.73 20.79 21.59 18.73 0.99
Depreciation 163.25 124.69 180.10 220.65 253.80 281.17 287.95 346.74 291.40 415.05 441.04 441.04 441.04 1.11
Interest 325.60 69.05 119.99 238.23 310.93 337.11 367.61 371.35 341.11 284.28 284.96 284.96 284.96 0.99
Interest Coverage Ratio 2.12 9.91 4.71 3.74 3.21 2.96 1.66 3.38 3.96 5.36 6.19 7.31 5.39 1.11
Profit before tax 296.57 517.89 240.59 114.11 341.13 207.28 40.33 542.23 737.64 859.08 1,075.92 1,355.89 810.77 1.13
Profit before tax % 8.51 13.81 7.04 2.67 6.65 3.60 0.70 9.43 12.58 11.43 12.41 14.06 9.88 1.03
Tax 26.71 95.94 13.36 68.42 152.36 69.64 80.48 155.41 163.02 224.67 300.54 28% 28% 1.27
Tax % 9.01 18.53 5.55 59.96 44.66 33.60 199.55 28.66 22.10 26.15 27.93 0.02 0.03 1.13
Net profit 283.18 421.46 229.72 14.56 152.73 109.04 -57.76 391.83 575.65 642.81 780.32 977.15 584.29 1.10
Net profit % 8.13 11.24 6.72 0.34 2.98 1.89 -1.00 6.82 9.82 8.55 9.00 10.13 7.12 1.01
EPS 19.19 26.54 14.42 0.91 9.59 6.84 -3.63 24.59 36.13 40.35 48.98 61.34 36.68 1.09
Price to earning 5.67 12.20 12.85 203.91 18.03 24.62 -44.42 16.26 22.47 20.46 14.44 18.41 14.44 1.15
Price 108.82 323.80 185.25 186.36 172.83 168.51 161.03 399.99 811.86 825.46 707.50 1,129.17 529.77 1.25
#DIV/0!
RATIOS: #DIV/0!
Dividend Payout 7.82% 7.54% 13.87% 328.23% 31.29% 42.51% 0.00% 11.90% 8.12% 7.27% 0.99
OPM 19.79% 18.26% 16.53% 20.87% 19.46% 17.34% 10.60% 21.85% 23.06% 20.25% 20.33% 1.00
Price/Sales 3.12%
TRENDS: 10 YEARS 7 YEARS 5 YEARS 3 YEARS RECENT BEST WORST
Sales Growth 8.92% 11.91% 7.93% 9.34% 28.26% 28.26% 7.93%
OPM 18.87% 19.05% 18.73% 21.59% 20.33% 21.59% 18.73%
Price to Earning 35.09 45.74 19.65 18.41 14.44 18.41 14.44
Sales 98% 105% 110% 97% 105% 126% 109%
Expenses 99% 108% 115% 94% 110% 124% 109%
Operating Profit 92% 97% 92% 111% 91% 136% 110%
Net profit 88% 83% 126% 98% 87% 166% 73%
JUBILANT LIFE SCIENCES LTD SCREENER.IN
Narration Jun-16 Sep-16 Dec-16 Mar-17 Jun-17 Sep-17 Dec-17 Mar-18 Jun-18 Sep-18
Sales 1,419.53 1,385.50 1,458.22 1,598.18 1,556.30 1,641.82 2,067.76 2,251.96 2,078.65 2,269.49
Expenses 1,051.37 1,045.17 1,126.40 1,293.20 1,218.69 1,335.76 1,650.92 1,794.09 1,641.05 1,819.31
Operating Profit 368.16 340.33 331.82 304.98 337.61 306.06 416.84 457.87 437.60 450.18
Other Income 4.29 4.92 5.12 10.53 6.81 7.09 3.22 22.91 9.47 3.83
Depreciation 71.52 72.01 72.65 75.22 72.48 79.01 81.82 181.74 88.00 89.48
Interest 82.77 79.96 98.19 80.19 68.73 66.01 77.06 72.48 72.70 62.72
Profit before tax 218.16 193.28 166.10 160.10 203.21 168.13 261.18 226.56 286.37 301.81
Tax 54.24 49.72 47.99 11.07 59.50 42.66 48.34 74.16 86.00 92.04
Net profit 163.92 143.56 119.40 150.13 147.14 128.26 212.54 154.87 202.50 210.41
OPM 26% 25% 23% 19% 22% 19% 20% 20% 21% 20%
JUBILANT LIFE SCIENCES LTD SCREENER.IN
Narration Mar-09 Mar-10 Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18
Equity Share Capital 14.76 15.88 15.93 15.93 15.93 15.45 15.93 15.54 15.58 15.58
Reserves 1,527.89 2,185.46 2,156.34 2,241.10 2,460.19 2,611.07 2,437.59 2,950.72 3,420.47 4,070.95
Total Shareholder Funds 1,542.65 2,201.34 2,172.27 2,257.03 2,476.12 2,626.52 2,453.52 2,966.26 3,436.05 4,086.53
Borrowings 3,941.79 3,172.73 3,925.63 3,817.80 4,245.19 4,395.28 4,793.11 4,493.25 4,045.29 3,468.89
Other Liabilities 1,394.26 1,539.16 1,587.10 1,817.14 1,876.11 2,219.71 1,760.10 1,364.66 1,559.31 2,062.20
Total 6,878.70 6,913.23 7,685.00 7,891.97 8,597.42 9,241.51 9,006.73 8,824.17 9,040.65 9,617.62
Debt/Equity Ratio 2.56 1.44 1.81 1.69 1.71 1.67 1.95 1.51 1.18 0.85
Current Ratio 1.06 1.11 1.42 1.07 1.16 1.18 1.39 1.83 1.72 1.34
Net Block 3,745.00 3,818.89 3,991.05 4,460.17 4,967.46 5,098.78 4,911.33 5,104.42 5,106.73 5,400.55
Capital Work in Progress 503.11 505.63 666.71 685.55 436.89 472.39 596.60 611.32 683.78 670.97
Investments 271.36 256.41 32.75 19.20 25.61 33.99 39.50 85.43 102.71 123.52
Other Assets 2,359.23 2,332.30 2,994.49 2,727.05 3,167.46 3,636.35 3,459.30 3,023.00 3,147.43 3,422.58
Total 6,878.70 6,913.23 7,685.00 7,891.97 8,597.42 9,241.51 9,006.73 8,824.17 9,040.65 9,617.62
Working Capital 964.97 793.14 1,407.39 909.91 1,291.35 1,416.64 1,699.20 1,658.34 1,588.12 1,360.38
Debtors 504.41 518.61 520.45 652.69 708.54 805.87 819.28 950.50 1,005.31 1,130.76
Inventory 595.61 690.95 691.28 1,020.22 1,116.18 1,341.42 1,235.33 1,203.10 1,220.40 1,391.39
Debtor Days 52.83 50.49 55.55 55.79 50.39 51.05 52.00 60.35 62.60 54.90
Inventory Turnover 5.85 5.43 4.95 4.19 4.60 4.30 4.66 4.78 4.80 5.40
Narration Mar-09 Mar-10 Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18
Cash from Operating Activity 456.98 701.18 389.75 707.17 969.90 772.27 783.26 1,098.89 1,268.49 1,303.20 8,451.09 1.12
Cash from Investing Activity -1,856.59 -279.48 -455.07 -596.43 -503.57 -164.02 -362.43 -308.51 -465.44 -614.33 -5,605.87 0.88
Cash from Financing Activity 1,251.74 -298.02 608.21 -888.82 -449.76 -414.41 -502.69 -842.75 -685.87 -901.14 -3,123.51 -0.96
Net Cash Flow -147.87 123.68 542.89 -778.08 16.57 193.84 -81.86 -52.37 117.18 -212.27 -278.29
Net profit 283.18 421.46 229.72 14.56 152.73 109.04 -57.76 391.83 575.65 642.81 2,763.22 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
How to use it?
You can customize this workbook as you want.
You can add custom formating, add conditional formating, add your own formulas… do ANYTHING.
Please don't edit the "Data Sheet" only.
TESTING:
This is a testing feature currently.
You can report any formula errors on the worksheet at: screener.feedback@dalal-street.in
… do ANYTHING.
dalal-street.in
COMPANY NAME JUBILANT LIFE SCIENCES LTD
LATEST VERSION 2.10 PLEASE
CURRENT VERSION 2.10
META
Number of shares 15.93
Face Value 1
Current Price 707.5
Market Capitalization 11270.48
Quarters
Report Date Jun-16 Sep-16 Dec-16 Mar-17
Sales 1,419.53 1,385.50 1,458.22 1,598.18
Expenses 1,051.37 1,045.17 1,126.40 1,293.20
Other Income 4.29 4.92 5.12 10.53
Depreciation 71.52 72.01 72.65 75.22
Interest 82.77 79.96 98.19 80.19
Profit before tax 218.16 193.28 166.10 160.10
Tax 54.24 49.72 47.99 11.07
Net profit 163.92 143.56 119.40 150.13
Operating Profit 368.16 340.33 331.82 304.98
BALANCE SHEET
Report Date Mar-09 Mar-10 Mar-11 Mar-12
Equity Share Capital 14.76 15.88 15.93 15.93
Reserves 1527.89 2185.46 2156.34 2241.1
Borrowings 3941.79 3172.73 3925.63 3817.8
Other Liabilities 1394.26 1539.16 1587.1 1817.14
Total 6,878.70 6,913.23 7,685.00 7,891.97
Net Block 3745 3818.89 3991.05 4460.17
Capital Work in Progress 503.11 505.63 666.71 685.55
Investments 271.36 256.41 32.75 19.2
Other Assets 2359.23 2332.3 2994.49 2727.05
Total 6,878.70 6,913.23 7,685.00 7,891.97
Receivables 504.41 518.61 520.45 652.69
Inventory 595.61 690.95 691.28 1020.22
Cash & Bank 381.67 503.67 1045.14 266.82
No. of Equity Shares 147574258 158811775 159313139 159313139
New Bonus Shares
Face value 1 1 1 1
CASH FLOW:
Report Date Mar-09 Mar-10 Mar-11 Mar-12
Cash from Operating Activity 456.98 701.18 389.75 707.17
Cash from Investing Activity -1,856.59 -279.48 -455.07 -596.43
Cash from Financing Activity 1,251.74 -298.02 608.21 -888.82
Net Cash Flow -147.87 123.68 542.89 -778.08
DERIVED:
Adjusted Equity Shares in Cr 14.76 15.88 15.93 15.93
PLEASE DO NOT MAKE ANY CHANGES TO THIS SHEET
1 1 1 1 1 1